GeneNeer aims to become the world’s leading company for resilient crop seed innovation, with the safest, fastest response to crop loss caused by rapid climate change. Using its breakthrough gene-editing technology, based on Superlines and tissue-specific silencing capabilities, the company will provide eco-friendly plant protection against pests, viruses and other biotic stresses that threaten global food security.
| Website | https://geneneer.com |
| Employees | 10 (6 on RocketReach) |
| Founded | 2016 |
| Address | St. Boniface Hospital Research Centre, 351 Taché Avenue, Winnipeg, Manitoba R2H 2A6, CA |
| Industry | Biotechnology Research |
| Keywords | Gene Editing, Genome Editing, Genetic Engineering, Crop Improvement, Seed Technology, Agricultural Biotechnology, Crop Genetics, Crop Science, Plant Biotechnology, Plant Breeding, Agricultural Innovation, Crop Protection, Precision Breeding, Sustainable Agriculture, Agricultural Research, Tissue Culture, Food Security, Biotechnology |
| Competitors | Thermo Fisher Scientific, Boehringer Ingelheim, Agilent Technologies, Illumina, Eurofins, Bio-Rad Laboratories, QIAGEN, Sangamo Therapeutics, Inc., Takara Bio USA, Inc., Geno +31 more (view full list) |
Looking for a particular GeneNeer employee's phone or email?
Kinneret Shefer is the Chief Executive Officer and Cofounder of GeneNeer.
6 people are employed at GeneNeer.
GeneNeer is based in Winnipeg, Manitoba.